These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 29032202)
1. PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2. Miyamoto M; Komuro A Biochem Biophys Res Commun; 2017 Dec; 494(1-2):227-233. PubMed ID: 29032202 [TBL] [Abstract][Full Text] [Related]
2. The TAR-RNA binding protein is required for immunoresponses triggered by Cardiovirus infection. Komuro A; Homma Y; Negoro T; Barber GN; Horvath CM Biochem Biophys Res Commun; 2016 Nov; 480(2):187-193. PubMed ID: 27743889 [TBL] [Abstract][Full Text] [Related]
3. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Satoh T; Kato H; Kumagai Y; Yoneyama M; Sato S; Matsushita K; Tsujimura T; Fujita T; Akira S; Takeuchi O Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1512-7. PubMed ID: 20080593 [TBL] [Abstract][Full Text] [Related]
4. DHX29 functions as an RNA co-sensor for MDA5-mediated EMCV-specific antiviral immunity. Zhu Q; Tan P; Li Y; Lin M; Li C; Mao J; Cui J; Zhao W; Wang HY; Wang RF PLoS Pathog; 2018 Feb; 14(2):e1006886. PubMed ID: 29462185 [TBL] [Abstract][Full Text] [Related]
5. LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses. Sanchez David RY; Combredet C; Najburg V; Millot GA; Beauclair G; Schwikowski B; Léger T; Camadro JM; Jacob Y; Bellalou J; Jouvenet N; Tangy F; Komarova AV Sci Signal; 2019 Oct; 12(601):. PubMed ID: 31575732 [TBL] [Abstract][Full Text] [Related]
6. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. Deddouche S; Goubau D; Rehwinkel J; Chakravarty P; Begum S; Maillard PV; Borg A; Matthews N; Feng Q; van Kuppeveld FJ; Reis e Sousa C Elife; 2014 Feb; 3():e01535. PubMed ID: 24550253 [TBL] [Abstract][Full Text] [Related]
7. LGP2: positive about viral sensing. Moresco EM; Beutler B Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1261-2. PubMed ID: 20133887 [No Abstract] [Full Text] [Related]
8. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. Venkataraman T; Valdes M; Elsby R; Kakuta S; Caceres G; Saijo S; Iwakura Y; Barber GN J Immunol; 2007 May; 178(10):6444-55. PubMed ID: 17475874 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of ATP hydrolysis of RIG-I-like receptors by transactivation response RNA-binding protein. Chunhaphinyokul B; Hosokai E; Miyamoto M; Komuro A Biosci Rep; 2023 May; 43(5):. PubMed ID: 37078499 [TBL] [Abstract][Full Text] [Related]
10. PACT Facilitates RNA-Induced Activation of MDA5 by Promoting MDA5 Oligomerization. Lui PY; Wong LR; Ho TH; Au SWN; Chan CP; Kok KH; Jin DY J Immunol; 2017 Sep; 199(5):1846-1855. PubMed ID: 28760879 [TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors. Esser-Nobis K; Hatfield LD; Gale M Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931 [TBL] [Abstract][Full Text] [Related]
12. LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Bruns AM; Horvath CM Cytokine; 2015 Aug; 74(2):198-206. PubMed ID: 25794939 [TBL] [Abstract][Full Text] [Related]
13. Encephalomyocarditis Virus Abrogates the Interferon Beta Signaling Pathway via Its Structural Protein VP2. Han Y; Xie J; Xu S; Bi Y; Li X; Zhang H; Idris A; Bai J; Feng R J Virol; 2021 Feb; 95(6):. PubMed ID: 33328314 [TBL] [Abstract][Full Text] [Related]
14. TRIM13 is a negative regulator of MDA5-mediated type I interferon production. Narayan K; Waggoner L; Pham ST; Hendricks GL; Waggoner SN; Conlon J; Wang JP; Fitzgerald KA; Kang J J Virol; 2014 Sep; 88(18):10748-57. PubMed ID: 25008915 [TBL] [Abstract][Full Text] [Related]
15. LGP2 plays a critical role in MDA5-mediated antiviral activity against duck enteritis virus. Huo H; Zhao L; Wang D; Chen X; Chen H Mol Immunol; 2019 Dec; 116():160-166. PubMed ID: 31675523 [TBL] [Abstract][Full Text] [Related]
16. ZFYVE1 negatively regulates MDA5- but not RIG-I-mediated innate antiviral response. Zhong X; Feng L; Zang R; Lei CQ; Yang Q; Shu HB PLoS Pathog; 2020 Apr; 16(4):e1008457. PubMed ID: 32251420 [TBL] [Abstract][Full Text] [Related]
17. Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication. Gillich N; Zhang Z; Binder M; Urban S; Bartenschlager R J Hepatol; 2023 Jan; 78(1):78-89. PubMed ID: 36152765 [TBL] [Abstract][Full Text] [Related]
18. Paramyxovirus V protein interaction with the antiviral sensor LGP2 disrupts MDA5 signaling enhancement but is not relevant to LGP2-mediated RLR signaling inhibition. Rodriguez KR; Horvath CM J Virol; 2014 Jul; 88(14):8180-8. PubMed ID: 24829334 [TBL] [Abstract][Full Text] [Related]
19. Viral RNA recognition by LGP2 and MDA5, and activation of signaling through step-by-step conformational changes. Duic I; Tadakuma H; Harada Y; Yamaue R; Deguchi K; Suzuki Y; Yoshimura SH; Kato H; Takeyasu K; Fujita T Nucleic Acids Res; 2020 Nov; 48(20):11664-11674. PubMed ID: 33137199 [TBL] [Abstract][Full Text] [Related]